Serena Williams Confirms 31-Pound Loss Using GLP-1 Medication

Serena Williams has publicly confirmed using GLP-1 medications, such as Wegovy and Zepbound, for weight loss, revealing she lost over 31 pounds after struggling to return to her desired weight postpartum. Despite her lifelong dedication to training and healthy eating, Williams found it difficult to shed weight after the births of her daughters Alexis Olympia in 2017 and Adira in 2023. She began using the medication in 2024 after finishing breastfeeding, and now feels physically and mentally lighter and healthier. Williams is partnering with telehealth company Ro, not only as a patient but also as a paid spokesperson, aiming to destigmatize the use of these medications. She emphasizes that using GLP-1 drugs is not a shortcut but an enhancement to a healthy lifestyle, highlighting the importance of transparency about her journey. Her husband, Alexis Ohanian, is an investor and board member at Ro, strengthening the personal connection to the campaign.